Opicinumab
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Opicinumab, covering 2017-01-09 to 2017-01-09. Get the full timeline:
Most recent: Clinical Trial Update: Safety Study of BIIB033 in Subjects With Multiple Sclerosis [Phase 1]